Kyowa Kirin funds research and education projects to improve diagnosis and care for rare hematologic cancers, with a focus on Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, and Sézary syndrome.
Funder: Kyowa Kirin
Due Dates: June 15, 2026 (full proposal due)
Funding Amounts: $5,000–$100,000 per project; payment may be milestone-based
Summary: Supports independent research, education, and advocacy initiatives focused on rare hematologic cancers and bone diseases, with current emphasis on improving education and care in Cutaneous T-Cell Lymphoma (CTCL).
Kyowa Kirin offers grants to advance research, education, and patient support in alignment with its mission to improve outcomes for patients, families, and medical professionals. The current Request for Proposal (RFP) focuses on supporting continuing medical education (CME) initiatives that address key challenges in the recognition and management of Cutaneous T-Cell Lymphoma (CTCL), specifically Mycosis Fungoides (MF) and Sézary syndrome (SS). Eligible projects should target gaps in timely diagnosis, disease heterogeneity, and the lack of standardized treatment pathways. Funding is also available for broader research and community/advocacy projects in rare hematologic and bone diseases.